Why is Par Drugs & Che. falling/rising?

As of 10-Sep, Par Drugs & Chemicals Ltd is experiencing a price increase, currently at 113.50, reflecting a rise of 5.4 or 5.0%. The stock has shown strong performance today, outperforming its sector by 4.42%. In terms of returns, over the past week, the stock has risen by 11.25%, and over the past month, it has increased by 12.40%. However, it is important to note that the stock has faced significant challenges, with a year-to-date decline of 42.94% and a one-year return of -52.20%. The company has a low debt-to-equity ratio and an attractive return on equity of 14.6, indicating a favorable valuation compared to peers. Despite these positive aspects, the company has reported negative results for the last three consecutive quarters, and its profits have fallen by 2.8% over the past year, contributing to ongoing concerns about its long-term growth potential. In the broader market context, the stock's recent short-term performance is notably stronger than the benchmark, with the Sensex only increasing by 1.04% over the past week and 2.50% over the past month. However, the stock has consistently underperformed against the benchmark over the last three years, highlighting a significant disparity in performance. While the current price movement may reflect a temporary rebound or market correction, the long-term outlook remains cautious due to the company's declining sales and operating profits, as well as its negative returns over the past year.